Literature DB >> 29754868

Attitudes Surrounding the Management of Neonates with Severe Necrotizing Enterocolitis.

Gillian C Pet1, Ryan M McAdams2, Lilah Melzer3, Assaf P Oron4, Simon P Horslen5, Adam Goldin3, Patrick J Javid3.   

Abstract

OBJECTIVES: To assess providers' recommendations as to comfort care versus medical and surgical management in clinical scenarios of newborns with severe bowel loss and to assess how a variety of factors influence providers' decision making. STUDY
DESIGN: We conducted a survey of pediatric surgeons and neonatologists via the American Pediatric Surgical Association and American Academy of Pediatrics Section of Neonatal-Perinatal Medicine. We examined how respondents' recommendations were affected by a variety of patient and provider factors.
RESULTS: There were 288 neonatologists and 316 pediatric surgeons who responded. Irrespective of remaining bowel length, comfort care was recommended by 73% of providers for a premature infant with necrotizing enterocolitis and 54% for a full-term infant with midgut volvulus. The presence of comorbidities and earlier gestational age increased the proportion of providers recommending comfort care. Neonatologists were more likely to recommend comfort care than surgeons across all scenarios (OR, 1.45-2.00; P < .05), and this difference was more pronounced with infants born closer to term. In making these recommendations, neonatologists placed more importance on neurodevelopmental outcomes (P < .001), and surgeons emphasized experience with long-term quality of life (P < .001).
CONCLUSION: Despite a contemporary survival of >90% in infants with intestinal failure, a majority of providers still recommend comfort care in infants with massive bowel loss. Significant differences were identified in clinical decision making between surgeons and neonatologists. These data reinforce the need for targeted education on long-term outcomes in intestinal failure to neonatal and surgical providers.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  intestinal failure; premature infant

Mesh:

Year:  2018        PMID: 29754868      PMCID: PMC6063789          DOI: 10.1016/j.jpeds.2018.03.074

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  23 in total

Review 1.  Pediatric Intestinal Failure.

Authors:  Christopher P Duggan; Tom Jaksic
Journal:  N Engl J Med       Date:  2017-08-17       Impact factor: 91.245

2.  Long-term health-related quality of life of patients with pediatric onset intestinal failure.

Authors:  Annika Mutanen; Silja Kosola; Laura Merras-Salmio; Kaija-Leena Kolho; Mikko P Pakarinen
Journal:  J Pediatr Surg       Date:  2015-06-03       Impact factor: 2.545

3.  Hospital and neurodevelopmental outcomes of extremely low-birth-weight infants with necrotizing enterocolitis and spontaneous intestinal perforation.

Authors:  T A Shah; J Meinzen-Derr; T Gratton; J Steichen; E F Donovan; K Yolton; B Alexander; V Narendran; K R Schibler
Journal:  J Perinatol       Date:  2011-12-08       Impact factor: 2.521

4.  Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis.

Authors:  Susan R Hintz; Douglas E Kendrick; Barbara J Stoll; Betty R Vohr; Avroy A Fanaroff; Edward F Donovan; W Kenneth Poole; Martin L Blakely; Linda Wright; Rosemary Higgins
Journal:  Pediatrics       Date:  2005-03       Impact factor: 7.124

5.  Improved survival in a multidisciplinary short bowel syndrome program.

Authors:  Biren P Modi; Monica Langer; Y Avery Ching; Clarissa Valim; Stephen D Waterford; Julie Iglesias; Debora Duro; Clifford Lo; Tom Jaksic; Christopher Duggan
Journal:  J Pediatr Surg       Date:  2008-01       Impact factor: 2.545

6.  Neurodevelopmental and Cognitive Outcomes in Children With Intestinal Failure.

Authors:  Patrick M Chesley; Sabrina E Sanchez; Lilah Melzer; Assaf P Oron; Simon P Horslen; F Curt Bennett; Patrick J Javid
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-07       Impact factor: 2.839

7.  Change of Outcomes in Pediatric Intestinal Failure: Use of Time-Series Analysis to Assess the Evolution of an Intestinal Rehabilitation Program.

Authors:  Carol Oliveira; Nicole T de Silva; Sanja Stanojevic; Yaron Avitzur; Ahmed M Bayoumi; Wendy J Ungar; Jeffrey S Hoch; Paul W Wales
Journal:  J Am Coll Surg       Date:  2016-03-18       Impact factor: 6.113

8.  Counselling variation among physicians regarding intestinal transplant for short bowel syndrome.

Authors:  Christy L Cummings; Karen A Diefenbach; Mark R Mercurio
Journal:  J Med Ethics       Date:  2013-08-21       Impact factor: 2.903

9.  Health-related quality of life in children with intestinal failure.

Authors:  Sabrina E Sanchez; Jarod P McAteer; Adam B Goldin; Simon Horslen; Colleen E Huebner; Patrick J Javid
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-09       Impact factor: 2.839

10.  Neurodevelopmental outcomes of extremely low birth weight infants with spontaneous intestinal perforation or surgical necrotizing enterocolitis.

Authors:  R Wadhawan; W Oh; S R Hintz; M L Blakely; A Das; E F Bell; S Saha; A R Laptook; S Shankaran; B J Stoll; M C Walsh; R D Higgins
Journal:  J Perinatol       Date:  2013-10-17       Impact factor: 2.521

View more
  3 in total

1.  Short Bowel Syndrome.

Authors:  Baddr A Shakhsheer; Brad W Warner
Journal:  Curr Treat Options Pediatr       Date:  2019-10-11

Review 2.  Multidisciplinary Management in Pediatric Ultrashort Bowel Syndrome.

Authors:  Christina Belza; Paul W Wales
Journal:  J Multidiscip Healthc       Date:  2020-01-09

3.  Five Hundred Patients With Gut Malrotation: Thirty Years of Experience With the Introduction of a New Surgical Procedure.

Authors:  Kareem Abu-Elmagd; George Mazariegos; Sherif Armanyous; Neha Parekh; Ayat ElSherif; Ajai Khanna; Beverly Kosmach-Park; Giuseppe D'Amico; Masato Fujiki; Mohammed Osman; Marissa Scalish; Amanda Pruchnicki; Elizabeth Newhouse; Ahmed A Abdelshafy; Erick Remer; Guilherme Costa; R Matthew Walsh
Journal:  Ann Surg       Date:  2021-10-01       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.